Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
- Conditions
- Covid19
- Interventions
- Device: Filtration FanBehavioral: Safe-home pamphletBehavioral: Mid-week phone call
- Registration Number
- NCT05777720
- Lead Sponsor
- Stanford University
- Brief Summary
Investigators are evaluating whether an intervention consisting of box-fans with MERV 16 filters ("filtration fans") and recommendations for improving ventilation in the home can reduce secondary spread of Covid19 from an index case to susceptible contacts within the home.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 200
- Household members live in a shared space (apartment, home) with others (as opposed to renting single rooms in a shared space, for example)
- At least 3 other people live in the household aside from index case
- If index case test positive day was over 2 days prior
- If half or more household members are thought to be infected already
- If household has fewer than 3 contacts interested in participating in the study
- If fewer than 3 contacts are expected to be present in the house for a majority of the following 7 days
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intervention Mid-week phone call Families are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts. Intervention Safe-home pamphlet Families are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts. Intervention Filtration Fan Families are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.
- Primary Outcome Measures
Name Time Method Incidence of Covid19 7th day since enrollment in the trial Investigators will measure the incidence of Covid19 in susceptible contacts on day 7.
- Secondary Outcome Measures
Name Time Method Average CO2 levels 7 days Investigators will measure 7 day average CO2 levels in the home (measured in parts per million)
Incidence of new upper respiratory symptoms 7th day since enrollment in the trial Investigators will measure reported new upper respiratory symptoms in susceptible contacts.
Trial Locations
- Locations (2)
San Mateo Medical Center
🇺🇸San Mateo, California, United States
Stanford University Medical Center
🇺🇸Stanford, California, United States